Summary of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2015

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

(In thousands)	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
Medical Indication	2015		2014		2015		2014
Antibiotic	$	3,005	$	3,361	$	9,355	$	11,069
Cardiovascular	8,457		21,331		45,729		42,779
Gallstone	20,489		988		48,969		3,490
Glaucoma	5,714		4,538		15,921		7,474
Gout	1,453		3,383		6,743		7,445
Migraine	6,722		4,787		19,455		9,851
Obesity	1,084		915		2,952		2,890
Pain Management	4,286		8,407		18,508		20,418
Thyroid Deficiency	36,720		28,292		114,601		74,560
Other	11,422		3,995		25,328		13,176
Total	$	99,352	$	79,997	$	307,561	$	193,152

Summary of products which accounted for at least 10% of net sales

	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
	2015		2014		2015		2014
Product 1	37	%	35	%	37	%	39	%
Product 2	21	%	1	%	16	%	2	%
Product 3	7	%	24	%	13	%	19	%

Summary of customers which accounted for at least 10% of net sales

	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
	2015		2014		2015		2014
Customer A	27	%	23	%	30	%	21	%
Customer B	15	%	7	%	10	%	7	%
Customer C	—	%	14	%	—	%	15	%